N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study

References

• Kallings L, Rigertz O, Silverstolpe I. Microbial contamination of medical preparations. Acta Pharm Sue 1966;3:219–228.
   PubMedGoogle Scholar
• Semwal UP, Sharma P, Sharma A, Singh GN. Evaluation of preservative effectiveness in ophthalmic drops by microbial challenge test. World J Pharm Sci 2015;3:31–36.
   Google Scholar
• British Pharmacopoeia. Efficacy of antimicrobial preservation. London: Stationery Office; 2013. Appendix XVI C.
   Google Scholar
• Jones L, Powell CH. Uptake and release phenomena in contact lens care by silicone hydrogel lenses. Eye Contact Lens 2013;39:29–36.
   PubMed Web of Science ®Google Scholar
• Harris MG, Gee A, Kusumoto R, Lee H. Survival of contaminating bacteria in over the counter artificial tears. J Am Optom Assoc 1996;67:676–680.
   PubMedGoogle Scholar
• Krishnan S, Sengupta S, Reddy PR, Ravindran RD. Secondary pseudomonas infection of fungal keratitis following use of contaminated natamycin eye drops: a case series. Eye (Lond) 2009;23:477–479.
   PubMed Web of Science ®Google Scholar
• Labbé A, Pauly A, Liang H, et al. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J Ocul Pharmacol Ther 2006;22:267–278.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Labbé A, Liang H, et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010;29:312–334.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim EJ, Kim YH, et al. In vivo effects of preservative-free and preserved prostaglandin analogs: mouse ocular surface study. Korean J Ophthalmol 2015;29:270–279.
   PubMedGoogle Scholar
• Lucero JC, inventor. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug using amino acids having net positive charge. US5504113; 1995.
   Google Scholar
• Tu EY. Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives. Saudi J Ophthalmol 2014;28:182–187.
   PubMedGoogle Scholar
• Coroi MC, Bungau S, Tit M. Preservatives from the eye drops and the ocular surface. Rom J Ophthalmol 2015;59:2–5.
   PubMedGoogle Scholar
• Aguayo BA, Yeung JY, Chan CC, Birt CM. Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opin Drug Metab Toxicol 2016;18:1–11.
   Google Scholar
• Baudouin C. The ocular surface in glaucoma. Cornea 2009;28:S14–S19.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106:556–563.
   PubMed Web of Science ®Google Scholar
• Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002;86:418–423.
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma 2003;12:486–490.
   PubMed Web of Science ®Google Scholar
• Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther 2010;27:837–845.
   PubMed Web of Science ®Google Scholar
• López Bernal D, Ubels JL. Quantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservatives. Curr Eye Res 1991;10:645–656.
   PubMed Web of Science ®Google Scholar
• Codling CE, Maillard JY, Russel AD. Aspects of the antimicrobial mechanisms of action of a polyquaternium and an amidoamine. J Antimicrob Chem 2003;51:1153–1158.
   PubMed Web of Science ®Google Scholar
• Ubels JL, Clousing DP, Van Haitsma TA, et al. Preclinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent. Curr Eye Res 2004;28:437–444.
   PubMed Web of Science ®Google Scholar
• Matoba AY, Peterson JR, Wilhelmus KR. Dendritiform keratopathy associated with exposure to polyquarternium-1, a common ophthalmic preservative. Ophthalmology 2016;123:451–456.
   PubMed Web of Science ®Google Scholar
• Paimela T, Ryhänen T, Kauppinen A, et al. The preservative polyquaternium-1 increases cytotoxicity and NF-kappaB linked inflammation in human corneal epithelial cells. Mol Vis 2012;18:1189–1196.
   PubMed Web of Science ®Google Scholar
• Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009;25:113–119.
   PubMed Web of Science ®Google Scholar
• Saher O, Ghorab DM, Mursi NM. Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis. Pharm Dev Technol 2016;21:600–610.
   PubMed Web of Science ®Google Scholar
• Noecker RJ. Protecting the ocular surface in glaucoma and keratoconjunctivitis sicca. A supplement to refractive Eyecare^® for ophthalmologists. Gainesville (FL): University of Florida, College of Medicine, Office of Continuing Medical Education, vol. 8; 2004:1–10.
   Google Scholar
• Reidmiller JS, Smith WL, Sawyer MM, et al. Antimicrobial properties of the chelating agent EDTA on Streptococcal bovine mastitis isolates. J Food Prot 2006;69:1460–1462.
   PubMed Web of Science ®Google Scholar
• Finnegan S, Percival SL. EDTA: an antimicrobial and antibiofilm agent for use in wound care. Adv Wound Care (New Rochelle) 2015;4:415–421.
   PubMed Web of Science ®Google Scholar
• Ghelardi E, Celandroni F, Gueye SA, et al. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions. J Ocul Pharmacol Ther 2013;29:586–590.
   PubMed Web of Science ®Google Scholar
• Herrero VR. Preservatives in ophthalmic formulations: an overview. Arch Soc Esp Oftalmol 2007;82:531–532.
   PubMedGoogle Scholar
• Denyer SP, Maillard JY. Cellular impermeability and uptake of biocides and antibiotics in gram-negative bacteria. Symp Ser Soc Appl Microbiol 2002;92(S1):35S–45S.
   Google Scholar
• Russell AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrob Chemother 2003;52:750–763.
   PubMed Web of Science ®Google Scholar
• Xu M, Sivak JG, McCanna DJ. Comparison of the effects of ophthalmic solutions on human corneal epithelial cells using fluorescent dyes. J Ocul Pharmacol Ther 2013;29:794–802.
   PubMed Web of Science ®Google Scholar
• Brignole-Baudouin F, Riancho L, Liang H, Baudouin C. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells. Curr Eye Res 2011;36:979–988.
   PubMed Web of Science ®Google Scholar
• Burstein NL, Klyce SD. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium. Invest Ophthalmol Vis Sci 1977;6:899–911.
   Google Scholar
• Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 1998;82:39–42.
   PubMed Web of Science ®Google Scholar
• De Saint Jean M, Debbasch C, Brignole F, et al. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res 2000;20:85–94.
   PubMed Web of Science ®Google Scholar
• Okabe K, Kimura H, Okabe J, et al. Effect of benzalkonium chloride on transscleral drug delivery. Invest Ophthalmol Vis Sci 2005;46:703–708.
   PubMed Web of Science ®Google Scholar
• Pham XT, Huff JW. Cytotoxicity evaluation of multipurpose contact lens solutions using an in vitro test battery. CLAO J 1999;25:28–35.
   PubMedGoogle Scholar
• Kaur IP, Lal S, Rana C, et al. Ocular preservatives: associated risks and newer options. Cutan Ocul Toxicol 2009;28:93–103.
   PubMed Web of Science ®Google Scholar
• Seiler JP. The mutagenic activity of sodium perborate. Mutat Res 1989;224:219–227.
   PubMed Web of Science ®Google Scholar
• Way WA, Matsumoto S, Apel LJ, et al. Purite as a non-disruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives. Presented at the Association for Research in Vision and Ophthalmology (ARVO), 2001 and Published Abstract Reference. Invest Ophthalmol Vis Sci 2001;42:S39.
   Web of Science ®Google Scholar
• Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther 2001;18:205–215.
   PubMed Web of Science ®Google Scholar
• Grant R, Ajello M, Vlass E. Salt water or high tech? A look at two new rinsing solutions for contact lenses. Optician 1996;212:38–41.
   Google Scholar
• Vaughan JS, Porter DA. A new in vitro method for assessing the potential toxicity of soft contact lens care solutions. CLAO J 1993;19:54–57.
   PubMedGoogle Scholar
• Paugh JR, Brennan NA, Efron N. Ocular response to hydrogen peroxide. Am J Optom Physiol Opt 1988;65:91–98.
   PubMedGoogle Scholar
• Kandikonda S, Oda D, Niederman R, Sorkin BC. Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells. Cell Adhes Commun 1996;4:13–24.
   PubMed Web of Science ®Google Scholar
• Senoo T, Obara Y, Joyce NC. EDTA: a promoter of proliferation in human corneal endothelium. Invest Ophthalmol Vis Sci 2000;41:2930–2935.
   PubMed Web of Science ®Google Scholar
• Battiloro G, Iannacci G, Lacerenza D. Effetti di un collirio con acido ialuronico, estratto di Echinacea e aminoacidi sulle alterazioni dell’epitelio corneale in pazienti glaucomatosi in terapia cronica ipotonizzante. Ottica Fisiopatol 2013;XVIII:49–57 (Paper in Italian).
   Google Scholar